Accueil/Actions/AURA

AURA

USD

Aura Biosciences Inc. Common Stock

$5.680-0.270 (-4.538%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$5.950

Haut

$5.960

Bas

$5.630

Volume

0.05M

Fondamentaux de l'Entreprise

Capitalisation Boursière

352.8M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.24M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $4.345Actuel $5.680Haut $11.29

Rapport d'Analyse IA

Dernière mise à jour: 3 nov. 2025

Généré par l'IASource des Données: Yahoo Finance, Bloomberg, SEC

AURA Biosciences (AURA): Mixed Signals Near $6.10 Support Level

News Sentiment: Positive Catalysts Without Market Conviction

Aura Biosciences received two bullish signals from analysts and corporate events:

H.C. Wainwright Conference Participation (Sep 3): Failed to generate immediate momentum despite potential for investor visibility.
Analyst Buy Rating (Aug 13): Maintained a $22 price target--360% above current prices--but the stock hasn’t responded.

Market reaction to news appears muted. While analyst commentary remains optimistic, shares have traded flat-to

Actualités Connexes

3 sept. 2025 · 11:00

GlobeNewswire

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function,